ArticleHeart rhythm O22026
Characteristics, pathophysiological mechanisms, and ablation outcomes of patients with de novo left atrial flutter compared with patients with postablation left atrial flutter.
Article in Heart rhythm O2, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Observations about left atrial tachycardias: Broadening our understanding.Heart rhythm O2 · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Left atrial flutter (LAF) most commonly arises in patients with previous left atrial ablation or surgery. Rarely, it can present as a de novo arrhythmia without previous interventions. Objective: We aimed to compare patient characteristics, pathophysiological mechanisms, and ablation outcomes of patients with de novo LAF with those of patients with postablation LAF. Methods: Patients undergoing LAF ablation between January 2021 and June 2023 were included. Baseline data, arrhythmia mechanisms, and ablation targets were collected. Patients were followed with 7-day Holter electrocardiograms at 3, 6, and 12 months. The primary endpoint was arrhythmia recurrence after a 90-day blanking period. Results: A total of 147 patients with LAF were analyzed (median age 71 years; 65% men). Of those, 32 (22%) presented with de novo LAF, and 115 (78%) presented with postablation LAF. Patients in the de novo group were older (74 years vs 70 years; Conclusion: Patients with de novo LAF are older and leaner than patients with postablation LAF, and the predominant arrhythmia mechanism is anteroseptal localized reentry. Arrhythmia-free survival is similar in both groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.